TCG Advisory Services »

Summit Therapeutics shares owned by TCG Advisory Services

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by TCG Advisory Services from 13F filings

Historical chart of TCG Advisory Services investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by TCG Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by TCG Advisory Services

Quarter filed Position value Share count Share price at filing
2026-06-30 $440k 30k 14.57

More positions owned by TCG Advisory Services

NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Aiai Holdings Corp Com Cl A
Vanguard Index Fds Total Stk Mkt (VTI)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Amazon (AMZN)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr 0-3 Mth Treasury (SGOV)
American Centy Etf Tr Intl Eqt Etf (AVDE)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Broadcom (AVGO)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Blackrock Etf Trust Ii Isha Flex In Etf (BINC)

View all positions for TCG Advisory Services

Top funds holding Summit Therapeutics

Baker Bros. Advisors
FMR
BlackRock
T. Rowe Price Associates
State Street Corporation
Vanguard Capital Management
UBS Group
Vanguard Portfolio Management
Goldman Sachs Group
Point72 Asset Management
Geode Capital Management
Citadel Advisors
Susquehanna International
Millennium Management
Adage Capital Partners GP

View all funds holding Summit Therapeutics